Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey Scott Cole currently holds 150,000 shares of Cadrenal Therapeutics, Inc. (CVKD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Scott Cole has been a net neutral trader of CVKD stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey Scott Cole's most recent insider trade was on Apr 2, 2024, when they sold 150,000 shares at $0.00 per share.
Jeffrey Scott Cole serves as Executive at Cadrenal Therapeutics, Inc. (CVKD). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Jeffrey Scott Cole holds the position of Executive at Cadrenal Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Jeffrey Scott Cole has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jeffrey Scott Cole was on Apr 2, 2024, when they purchased $0 worth of CVKD shares. This transaction involved 150,000 shares at N/A per share.
Jeffrey Scott Cole currently owns 150,000 shares of Cadrenal Therapeutics, Inc. (CVKD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey Scott Cole's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey Scott Cole has 1 Form 4 filings on record as an insider at Cadrenal Therapeutics, Inc..
Set alerts for Jeffrey Scott Cole and 40,000+ other insiders.